Yposkesi
Yposkesi, a contract development and manufacturing organization (CDMO) focused on the production of gene therapy drugs, announces a new chapter in its development by welcoming the SK Group as a new majority shareholder, alongside shareholders AFM-Téléthon and Bpifrance. By forging a strong industrial partnership, Yposkesi will strengthen its production capacity at its site in Corbeil-Essonnes (near Paris), France, to meet the growing demand for gene therapy treatments for rare and common diseases. The company will strengthen its ability to innovate and develop processes for the benefit of its customers. The SK Group holds a 70% stake in Yposkesi, while the founding shareholders will deduct a 25% stake for H-MRB (AFM-Telethon/Généthon/CECS) and 5% for Bpifrance. They will both be involved in the decisions taken by the Board of Directors.
“The involvement of the SK Group in Yposkesi marks a new chapter in the development of the production platform we created more than four years ago. It will double the production capacity at the Corbeil-Essonnes site and strengthen its capacities in terms of technological innovation, thus accelerating the industrialization of gene therapies, a global challenge in which Yposkesi will play a major role,” said Frédéric Revah, Chief Executive Officer of Genethon and President of H-MRB (AFM-Telethon/Genethon/CECS).
XENOTHERA
Nantes-based biotech company XENOTHERA, which is developing a proprietary “glyco-humanized” antibody technology platform based on dual expertise in genetics and immunology, announced today that it has completed a €20 million financing round. This new round of financing is financed by the current shareholders, including Didier Rousseau, FAMM’s President and Founder, and welcomes a number of new investors, in particular the European fund EIC Fund, the holding company Nabuboto, the French fund Anaxago Capital (Objectif Innovation 18), and the social security group Malakoff Humanis (a French company that provides financial services to the public). The capital increase will enable the Nantes-based company, which has become better known through the development of its anti-COVID-19 treatment, XAV-19, to accelerate its growth and develop its product portfolio.
In just a few years, the Nantes-based company has brought two products to the clinical stage, LIS1, an immunosuppressant for transplantation, and XAV-19, an anti-SARS-CoV-2 antibody. In addition, it is developing XAB05, a preventive treatment for infections by multi-resistant bacteria, and a very promising portfolio in oncology.
May this year bring health & happiness
We have the habit of presenting you our wishes “in painting” … by putting forward artists to expose their visions of the world and their intuitions on what is essential to us …
This year, the Finpact team has chosen Takuma TANAKA, a painter based in Japan, who invites us through his work “2021”, to connect with each other, to find our happiness.
We wish you a new year full of beautiful encounters that will bring your continuous happiness and good health.
In 2021, we will continue to support the financing of innovation to improve our health and our environment.
Happy New Year to each and every one of you.
The Finpact team.
CARWATT _ Fundraising
Frontrunner in retrofitting & upcycling batteries of automotive batteries
CARWATT has raised more than €1 million in debt and equity in 2020 to deploy its solutions for decarbonizing mobility through the circular economy.
“Carwatt already offers electrical adaptations for diesel vehicles at airports or ports, such as small tractors or aircraft pushers. In these configurations, the aim is to extend the life of these vehicles, which only travel short distances at low speeds, and to limit pollutant emissions. We even use second-life batteries, both for the recycling and the enhancing of our solution’s economic performance.
These financial resources will enable us to continue our development and applications in various fields of activity.”
Eric PLANCHAIS _ Managing Partner _ CARWATT
TOOVALU _ Fundraising
Publisher of an innovative software solution that helps companies to manage their climate and CSR strategy, with their extra-financial indicators at all levels of the company, Toovalu opens its capital to a group of investors / entrepreneurs committed to accelerating the deployment of the solution. This fund raising will allow the company to accelerate its development, to better respond to the strong demand by intensifying R&D and by recruiting new talents.
“To offer solutions that meet the climate challenges and make the 1.5°C Trajectory possible! It will also be the opportunity to expand our offer and our impact to more companies such as Impact Observer or mission company”.
Marie GABORIT _ Managing Partner TOOVALU. April 2020.
Ecovelo _ Fundraising
Nantes, May 05, 2020 – Ecovelo (Human concept SAS) closes a €2M financing round with Banque des Territoires, GO CAPITAL (via the fund OUEST VENTURES III) and Parthal. The operation is coupled with a bank debt raising of 1.3 M€. Thanks to this financing, the Nantes-based company, which designs and supplies innovative turnkey hybrid self-service bicycle solutions, intends to accelerate its development with local authorities and transport operators.
“We have found our customers, proven our value and our difference to better meet the needs of small and medium-sized communities. We have a reassuring business model and the right partners to support us in this adventure. We feel a certain urgency to deploy our solutions. This financing operation is in line with our strategy and consolidates our history, I am delighted.”
Sebastien BOURBOUSSON. CEO Ecovelo (Human Concept). May 2020
Finple _ M&A
Finple welcomes the Consultim Group and its majority shareholder BlackFin Capital Partners to its capital. The Consultim Group has acquired a majority stake in Finple, which has become Finple by Consultim.
“In a favorable environment, we wanted to be backed by a group that would enable us to accelerate our growth in the coming years. Our goal is to finance the real economy to the tune of €100 million per year by 2022. It was to meet this ambition that we decided to join forces with the Consultim Group. We share the group’s entrepreneurial values and are keen to offer investors new asset classes.” Thomas DEROSNE. President FINPLE
Happy New Year 2020
The Finpact team joins the message of the Artist Ángel Moyano Rivas who invites us in his work « Love Wild Nature » to love and perhaps also, to consider wild nature …
We present you our best wishes for this new year.
2019 _ Ángel Moyano Rivas
______
CityTaps _ Fundraising
“We are delighted to announce that CityTaps has raised 2.2m€ from a variety of institutional and private investors to fund our #impact and #growth over the next few years. We continue to target #sdg6 and #runningwaterineveryhome in their daily work. We thank the #investors for their trust and confidence. #tech4good #water #fundraising“
Gregoire LANDEL. CEO CityTaps _ Oct. 2019
Zéphyr & Borée _ Fundraising
“We are proud to announce the entry of SOPER, the investment fund of Jean-Michel Germa, and Francis Vallat to the capital of Zéphyr & Borée. SOPER has an expertise in technologies such as batteries, hydrogen, solar energy, biofuels that Zéphyr&Borée wishes to study to implement as a complement the wind propulsion. This fund raising coupled with the expertise of Jean-Michel and Francis will allow Zéphyr&Borée to accelerate the deployement of its projects aiming the decarbonation of shipping.”
Nils Joyeux. CEO Zephir & Borée / December 2019.
